1.Thyrum, P, Yeh, C, Potkin, S, et al. Safety and tolerability of switching from conventional antipsychotic therapy to seroquel (quetiapine fumarate) followed by abrupt withdrawal from seroquel. Poster presentation at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, Hawaii, December, 1997.Google Scholar

2.Arvantis, L, Miller, B, Kowalcyk, B. Efficacy of seroquel (quetiapine fumarate) in affective symptoms of schizophrenia. Poster presentation at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, Hawaii, December, 1997.Google Scholar

3.Goldstein, J, Arvantis, L, Cantillon, M. Low incidence of reproductive/hormonal side effects with seroquel (quetiapine fumarate) is supported by its lack of elevation of plasma prolactin concentration. Poster presentation at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, Hawaii, December, 1997.Google Scholar

4.Cantillon, M, Arvantis, L, Miller, B, Kowalcyk, B. Seroquel (quetiapine fumarate) reduces hostility and aggression in patients with acute schizophrenia. Poster presentation at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, Hawaii, December, 1997.Google Scholar